Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis
暂无分享,去创建一个
B. Tomlinson | L. Tam | E. Li | Tena K. Li | T. Chu
[1] B. Joffe,et al. Insulin resistance and impaired beta cell function in rheumatoid arthritis. , 2006, Arthritis and rheumatism.
[2] M. Cutolo,et al. Effects of Anti‐TNF‐α Treatment on Lipid Profile in Patients with Active Rheumatoid Arthritis , 2006 .
[3] A. Drosos,et al. Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis. , 2006, The Journal of rheumatology.
[4] D. Borderie,et al. Effects of repeated infliximab therapy on serum lipid profile in patients with refractory rheumatoid arthritis. , 2006, Clinica chimica acta; international journal of clinical chemistry.
[5] O. Johnson,et al. Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long‐term infliximab therapy , 2006, Scandinavian journal of rheumatology.
[6] C. Turesson,et al. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. , 2005, The Journal of rheumatology.
[7] B. Dijkmans,et al. Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritis. , 2005, The Journal of rheumatology.
[8] A. Drosos,et al. Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis , 2004, Annals of the rheumatic diseases.
[9] M. Netea,et al. Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis , 2004, Annals of the rheumatic diseases.
[10] Claude Lenfant,et al. Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[11] I. McInnes,et al. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. , 2003, Circulation.
[12] E. Cauza,et al. Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis. , 2002, Wiener klinische Wochenschrift.
[13] B. Joffe,et al. Effects of disease modifying agents and dietary intervention on insulin resistance and dyslipidemia in inflammatory arthritis: a pilot study , 2002, Arthritis research.
[14] G. McColl,et al. Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? , 2002, Arthritis and rheumatism.
[15] J. Després,et al. The Dense LDL Phenotype: Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men , 1996, Diabetes Care.
[16] B. Spiegelman,et al. IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.
[17] E. Shiloni,et al. Mechanism of the hypertriglyceridemia induced by tumor necrosis factor administration to rats. , 1989, Biochimica et biophysica acta.
[18] M. Cutolo,et al. Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis. , 2006, Annals of the New York Academy of Sciences.
[19] M. González-Gay,et al. Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. , 2006, Clinical and experimental rheumatology.
[20] R. Maini,et al. The Role of Cytokines in Rheumatoid Arthritis , 1996, Journal of the Royal College of Physicians of London.